Novel Artificial Intelligence and Telemedicine Patent Application Propels Innovega into [...]
Company’s first deployment of its eMacula system targets the visually [...]
New resources support development for initial launch and expanded markets. [...]
Novel Systems Help Eye Care Practitioners Achieve Customization for [...]
This Reg CF offering is made available through StartEngine Primary, LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
© Copyright 2026 Innovega, Inc. | All rights reserved. | Developed by Pointed Services
